Here are three points:
1. The individual targets of the analysts range between $45 and $98.
2. For the current fiscal quarter, analysts expect the company to deliver $1.02 in earnings per share.
3. Medtronic’s 50-day moving average is $6.15 and its 200-day moving average is $85.23.
More articles on devices:
NuVasive, Bioventus, DFINE & more: 17 key notes
Medtech sells 13 ROSA robots in Q4 2016 — 5 highlights
Dr. Nicole Ehrhart’s preclinical study affirms AlloStem Cellular Bone Allograft effectiveness: 5 key takeaways
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.
